Anti-CP46A/ CYP46A1/ CP46 functional antibody

Anti-CP46A/ CYP46A1/ CP46 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CYP46A1/CYP46A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T64242-Ab-1/ GM-Tg-hg-T64242-Ab-2Anti-Human CYP46A1 monoclonal antibodyHuman
GM-Tg-rg-T64242-Ab-1/ GM-Tg-rg-T64242-Ab-2Anti-Rat CYP46A1 monoclonal antibodyRat
GM-Tg-mg-T64242-Ab-1/ GM-Tg-mg-T64242-Ab-2Anti-Mouse CYP46A1 monoclonal antibodyMouse
GM-Tg-cynog-T64242-Ab-1/ GM-Tg-cynog-T64242-Ab-2Anti-Cynomolgus/ Rhesus macaque CYP46A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T64242-Ab-1/ GM-Tg-felg-T64242-Ab-2Anti-Feline CYP46A1 monoclonal antibodyFeline
GM-Tg-cang-T64242-Ab-1/ GM-Tg-cang-T64242-Ab-2Anti-Canine CYP46A1 monoclonal antibodyCanine
GM-Tg-bovg-T64242-Ab-1/ GM-Tg-bovg-T64242-Ab-2Anti-Bovine CYP46A1 monoclonal antibodyBovine
GM-Tg-equg-T64242-Ab-1/ GM-Tg-equg-T64242-Ab-2Anti-Equine CYP46A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T64242-Ab-1/ GM-Tg-hg-T64242-Ab-2; GM-Tg-rg-T64242-Ab-1/ GM-Tg-rg-T64242-Ab-2;
GM-Tg-mg-T64242-Ab-1/ GM-Tg-mg-T64242-Ab-2; GM-Tg-cynog-T64242-Ab-1/ GM-Tg-cynog-T64242-Ab-2;
GM-Tg-felg-T64242-Ab-1/ GM-Tg-felg-T64242-Ab-2; GM-Tg-cang-T64242-Ab-1/ GM-Tg-cang-T64242-Ab-2;
GM-Tg-bovg-T64242-Ab-1/ GM-Tg-bovg-T64242-Ab-2; GM-Tg-equg-T64242-Ab-1/ GM-Tg-equg-T64242-Ab-2
Products NameAnti-CYP46A1 monoclonal antibody
Formatmab
Target NameCYP46A1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CYP46A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T64242-Ag-1Recombinant multi-species CP46A/ CYP46A1/ CP46 protein
    ORF Viral VectorpGMLPm005074mouse Cyp46a1 Lentivirus plasmid
    ORF Viral VectorvGMLPm005074mouse Cyp46a1 Lentivirus particle


    Target information

    Target IDGM-T64242
    Target NameCYP46A1
    Gene ID10858,13116,362782,705843,480432,101093112,506438,100051131
    Gene Symbol and SynonymsCH24H,CP46,CYP46,CYP46A1
    Uniprot AccessionQ9Y6A2
    Uniprot Entry NameCP46A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000036530
    Target ClassificationN/A

    The target: CYP46A1, gene name: CYP46A1, also named as CP46, CYP46. This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein is expressed in the brain, where it converts cholesterol to 24S-hydroxycholesterol. While cholesterol cannot pass the blood-brain barrier, 24S-hydroxycholesterol can be secreted in the brain into the circulation to be returned to the liver for catabolism. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.